Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 23 Breast Neoplasms 16 Neoplasms by Site 2 Neoplasms 2 Neoplasm Metastasis 2 Breast Diseases 2 Stage II Prostate Adenocarcinoma 1 Skin Diseases 1 Sexual Dysfunctions, Psychological 1 Salivary Gland Neoplasms 1 Prostatic Neoplasms, Castration-Resistant 1 Prostate Cancer Metastatic Disease 1 Prostate Cancer Metastatic 1 Ovarian Neoplasms 1 Oligometastatic Prostate Carcinoma 1 Metastatic Neuroendocrine Prostate Cancer 1 Metastatic Castration-resistant Prostate Cancer 1 Metastatic Castration-Resistant Prostate Cancer 1 Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer 1 Endometrial Neoplasms 1 Dementia 1 Cognitive Dysfunction 1 Anatomic Stage III Breast Cancer AJCC v8 1 Advanced Breast Cancer 1

Interventions

Letrozole 5 Fulvestrant 5 trastuzumab deruxtecan 3 Injections 3 toripalimab 2 sacituzumab govitecan 2 palbociclib 2 elacestrant 2 abemaciclib 2 Anastrozole 2 AZD9833 2 ribociclib 1 pyrotinib 1 exemestane 1 eribulin 1 disitamab vedotin 1 dalpiciclib 1 Vinorelbine 1 Selective Estrogen Receptor Modulators 1 Ritonavir 1 RAD1901 1 Paclitaxel 1 Lead 1 Itraconazole 1 Goserelin 1 Gonadotropin-Releasing Hormone 1 Everolimus 1 Docetaxel 1 Bevacizumab 1 Aromatase Inhibitors 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Breast Cancer × Gonadotropin-Releasing Hormone × 1 year × Clear all

NCT06382948 2026-04-03

ADELA

MedSIR

Phase 3 Recruiting

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡